| 000 | 00616naa a2200205 4500 | ||
|---|---|---|---|
| 001 | 130599 | ||
| 003 | ES-MaBCM | ||
| 005 | 20241016144517.0 | ||
| 008 | 060714s2006 gbr|r0p 0 ||eng d | ||
| 021 | _axx | ||
| 035 | _a(OCoLC)1374262473 | ||
| 040 | _cES-MaBCM | ||
| 100 | 1 |
_aCohen, Jillian Clare _972786 |
|
| 245 | 1 | 0 |
_aPharmaceuticals and corruption _b: a risk assessment _cJillian Clare Cohen |
| 650 | 2 | 7 |
_aCorrupción _958157 |
| 650 | 7 |
_aSanidad _960177 |
|
| 650 | 7 |
_aEstablecimiento farmacéutico _958688 |
|
| 773 | 0 |
_aEn: _tGlobal corruption report _dLondon _w128063 _g(2006), p. 77-85 |
|
| 942 | _cAREV | ||
| 999 |
_c130599 _d130599 |
||